probable value of T-score in patients with known rates of calcification of the coronary and carotid arteries were obtained by regression analysis. These factors were equivalent density of coronary calcinoses (p=0,0046), the volume of the carotid calcifications (p=0,0039), the mass of calcifications of the carotid arteries (p=0,0054) and the presence of a stenosis of the carotid arteries (p=0.0001).The predictive model for estimating the probable value of T-score has been is designed using regression coefficients of each of the factors. Background: Despite the fact that Portugal has one of the lowest rates of hip fractures in Western Europe, more than 10.000 patients are admitted every year to the Portuguese National Health Service due to hip fragility fractures. The burden of the problem will tend to increase in coming years, unless effective preventive measures are put in place. ® was scored according to data available the day before the present HF (ie the current fracture was not considered as a previous fracture for the purpose of risk prediction). Thresholds for therapeutic intervention were defined according to PG: a 10-year probability of a major osteoporotic fracture (OF) ≥11% and/or a 10 year probability of HF ≥3% 1 . Results: The mean age of the population (n=130) was 81.6±8.6 years, and 69.2% were female. Before the current HF, only 23 (17.7%) of the patients had been prescribed some form of medication for OP: bisphosphonates (n=2), strontium ranelate (n=3) and calcium + vitamin D supplementation (n=13); the other patients or caregivers didn't specify the ongoing medication. About 65 patients had a previous fracture, of which 8 patients had ≥1 fragility fracture of the hip; 6 had ≥1 symptomatic vertebral fragility fracture and 16 had ≥2 fragility fractures, independently of the site of the fracture. According to PG, all these 30 (26%) patients should be under OT without the need for FRAX ® risk calculation. The mean 10-year major OF probability was 21.2±14% and the mean 10-year HF probability was 13.7±12.9%. According to FRAX ® , 104 (80%) of the patients had indication to start OT based on the 10-year risk of major OF and 117 (90%) based on the 10-year risk of HF. After hospitalization, although all the patients had formal indication for treatment, only 11 (8.5%) patients had received a prescription for OT up to one year after the fracture event.
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Results:
The mean age of the population (n=130) was 81.6±8.6 years, and 69.2% were female. Before the current HF, only 23 (17.7%) of the patients had been prescribed some form of medication for OP: bisphosphonates (n=2), strontium ranelate (n=3) and calcium + vitamin D supplementation (n=13); the other patients or caregivers didn't specify the ongoing medication. About 65 patients had a previous fracture, of which 8 patients had ≥1 fragility fracture of the hip; 6 had ≥1 symptomatic vertebral fragility fracture and 16 had ≥2 fragility fractures, independently of the site of the fracture. According to PG, all these 30 (26%) patients should be under OT without the need for FRAX ® risk calculation. The mean 10-year major OF probability was 21.2±14% and the mean 10-year HF probability was 13.7±12.9%. According to FRAX ® , 104 (80%) of the patients had indication to start OT based on the 10-year risk of major OF and 117 (90%) based on the 10-year risk of HF. After hospitalization, although all the patients had formal indication for treatment, only 11 (8.5%) patients had received a prescription for OT up to one year after the fracture event.
Conclusions: Similar to other countries, the percentage of patients under OT (before and after HF) in Portugal is extremely low. Risk estimation by FRAX ® and application of current PG would allow clinicians to identify these patients and introduce appropriate preventive measures. Continued efforts are needed to promote timely prevention, most especially after the first fragility fracture. Data analysis was done on R 3.3.2 software. Odds ratios were calculated using logistic regression and age adjusted models were compared using the likelihood ratio test. Categorical data was analysed using Chi squared and Fischer's exact test, while continuous data was analyzed using t-test.
The study population was a total of 306 patients with a mean age of 63.6 years. 146 of the study group had active disease, while 160 patient were breast cancer survivors. Of the total population 87 (28%) had sustained at least one fracture. Active breast cancer insignificantly increased fracture risk in comparison to the cancer survivor population (OR=1.330, 95% CI=0. 801-2.218, p=0.271) . Physical characteristics that significantly increased fracture risk included increased age and decreased average fat percentage (Table 1) . BMD reduction in the femoral neck and all vertebrae significantly increased odds of having a fracture (Table 2) . External factors such as smoking status, alcohol consumption, family history and steroid use had no significant effect. To analyze the economic impact of the FLS on pharmaceutical expenditure for osteoporosis. Methods: Expenditure on osteoporosis medication (government inpunt) was collected from January 1th, 2011 to October 1th, 2016. The data distinguish group I (calcium and vitamin D), group II (Bisphosphonates, denosumab, SERM, strontium and teriparatide) and total expenditure (sum of groups I and II). Intravenous bisphosphonates were not included. Gran Canaria island is organized in two health areas; the North and the South areas. The population aged >65 years in the North and South areas in 2016 were
